SARS-CoV-2 infection causes immunodeficiency in recovered patients by downregulating CD19 expression in B cells via enhancing B-cell metabolism
Abstract The SARS-CoV-2 infection causes severe immune disruption. However, it is unclear if disrupted immune regulation still exists and pertains in recovered COVID-19 patients. In our study, we have characterized the immune phenotype of B cells from 15 recovered COVID-19 patients, and found that h...
Main Authors: | Yukai Jing, Li Luo, Ying Chen, Lisa S. Westerberg, Peng Zhou, Zhiping Xu, Andrés A. Herrada, Chan-Sik Park, Masato Kubo, Heng Mei, Yu Hu, Pamela Pui-Wah Lee, Bing Zheng, Zhiwei Sui, Wei Xiao, Quan Gong, Zhongxin Lu, Chaohong Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-09-01
|
Series: | Signal Transduction and Targeted Therapy |
Online Access: | https://doi.org/10.1038/s41392-021-00749-3 |
Similar Items
-
The role of B cells in COVID-19 infection and vaccination
by: Shiru Chen, et al.
Published: (2022-08-01) -
Primary immunodeficiencies and B-cell lymphomas
by: María Anunciación Martín-Mateos, et al.
Published: (2016-01-01) -
Involvement of MST1/mTORC1/STAT1 activity in the regulation of B‐cell receptor signalling by chemokine receptor 2
by: Yingzi Zhu, et al.
Published: (2022-07-01) -
The regulators of BCR signaling during B cell activation
by: Yue Wen, et al.
Published: (2019-10-01) -
Simulation of the Dynamics of Primary Immunodeficiencies in B Cells
by: Gabriel Ndipagbornchi Teku, et al.
Published: (2018-08-01)